The projects of this SPORE will use human bladder cancer specimens and cell lines for translational research directed toward improving the early detection, prevention, and treatment of human bladder cancer. The Specimen Core will provide investigators at M. D. Anderson Cancer Center and other collaborating institutions with high-quality tissue samples from patients with bladder cancer diagnosed, treated, and followed at our institution. Standardized and centralized procedures have been established for tissue procurement, quality control, and processing, storage, and distribution of samples to individual investigators and will ensure optimal use of the samples according to the guidelines established by the Specimen Committee. Functions of the Specimen Core facility will include specimen procurement, processing, storage, histopathologic review, and management of both pathological and clinical databases as well as distribution of well-characterized specimens to project investigators. The computerized database contains both pathological and clinical records of all samples, both stored and distributed to individual investigators, and includes the results of individual SPORE projects to facilitate the efficient response of the core to the needs of investigators in this SPORE and at collaborating institutions. These resources will also be available for future distribution through the NCI Early Detection and Research Network. Two pathologists with expertise in bladder cancer and in all aspects of the Specimen Core operations, including histopathologic evaluation and quality control, will co-direct the facility. This Core will also maintain a bank of cell lines for distribution to the members of this SPORE and other investigators. This centralized comprehensive Specimen Core facility will provide support for the multidisciplinary and translational research projects outlined in this SPORE proposal.
The specific aims of the Specimen Core are as follows.
Specific Aim 1 : Provide technical services and pathology review of all clinical specimens utilized in the clinical and research projects outlined in the SPORE proposal.
Specific Aim 2 : Maintain a repository of urothelial carcinoma specimens, normal bladder tissue, and related specimens.
Specific Aim 3 : Retrieve paraffin-embedded tissue from M. D. Anderson Cancer Center archives and formalin-fixed and paraffin-embedded tissue from referring institutions.
Specific Aim 4 : Maintain and expand innovative and unique tissue resources.
Specific Aim 5 : Maintain a comprehensive relational database.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA091846-09
Application #
7932251
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
9
Fiscal Year
2009
Total Cost
$161,194
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Duplisea, Jonathan J; Mokkapati, Sharada; Plote, Devin et al. (2018) The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside. World J Urol :
Choi, Woonyoung; McConkey, David (2018) Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas D Eur Urol 73:e104-e105
Zhang, Miao; Adeniran, Adebowale J; Vikram, Raghunandan et al. (2018) Carcinoma of the urethra. Hum Pathol 72:35-44
Wang, Gang; Xiao, Li; Zhang, Miao et al. (2018) Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Hum Pathol 79:57-65
Zhang, Shizhen; Wang, Yan; Bondaruk, Jolanta et al. (2018) Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test. Eur Urol Focus :
Jazzar, Usama; Yong, Shan; Klaassen, Zachary et al. (2018) Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States. Cancer 124:3127-3135
Westhoff, Ellen; Wu, Xifeng; Kiemeney, Lambertus A et al. (2018) Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer. Int J Cancer 142:1797-1804
Shore, Neal D; Boorjian, Stephen A; Canter, Daniel J et al. (2017) Intravesical rAd-IFN?/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. J Clin Oncol 35:3410-3416
Lin, Moubin; Zhang, Liren; Hildebrandt, Michelle A T et al. (2017) Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer. Oncotarget 8:74936-74946
Metcalfe, Michael J; Ferguson, James E; Li, Roger et al. (2017) Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. Eur Urol Focus 3:577-583

Showing the most recent 10 out of 247 publications